Provided by Tiger Trade Technology Pte. Ltd.

Cohen & Steers

61.73
+0.35000.57%
Volume:7.09K
Turnover:438.76K
Market Cap:3.17B
PE:20.78
High:62.13
Open:61.77
Low:61.63
Close:61.38
52wk High:83.99
52wk Low:58.39
Shares:51.39M
Float Shares:27.58M
Volume Ratio:0.25
T/O Rate:0.03%
Dividend:2.48
Dividend Rate:4.02%
EPS(TTM):2.97
EPS(LYR):2.97
ROE:26.04%
ROA:13.15%
PB:5.65
PE(LYR):20.78

Loading ...

Cohen & Steers posts FY 2025 revenue of USD 556.1 million, up 7.5%

Reuters
·
Feb 27

Denali Therapeutics: Underappreciated Hunter Syndrome Launch and 2026 CNS Pipeline Catalysts Support Buy Rating

TIPRANKS
·
Feb 27

Press Release: Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a)

Dow Jones
·
Feb 27

Cohen & Steers RNP Sets $0.1360 Monthly Distribution for Feb. 27, 2026

Reuters
·
Feb 27

Cohen & Steers Raises Quarterly Dividend to $0.67 a Share, Payable March 19 to Holders of Record March 9

MT Newswires Live
·
Feb 27

Cohen & Steers raises quarterly dividend 8.1% to 67c from 62c per share

TIPRANKS
·
Feb 27

Press Release: Cohen & Steers, Inc. Declares Quarterly Dividend

Dow Jones
·
Feb 27

Bright Minds Biosciences to Present at Upcoming Conferences

GlobeNewswire
·
Feb 26

Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Wednesday, March 4, 2026

GlobeNewswire
·
Feb 25

Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference

GlobeNewswire
·
Feb 25

Axsome Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Feb 25

Buy Rating Backed by Reaccelerating Onapgo Demand, Sage Integration Upside, and Attractive CNS-Driven Valuation

TIPRANKS
·
Feb 25

Supernus Pharmaceuticals to Participate in March Investor Conferences

GlobeNewswire
·
Feb 24

Silo Pharma Announces Share Buyback Program

GlobeNewswire
·
Feb 24

Buy Rating on Axsome: Strong Commercial Momentum, Expanding CNS Pipeline, and Attractive Valuation Upside

TIPRANKS
·
Feb 23

Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors

GlobeNewswire
·
Feb 23

Axsome Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Feb 23

Dyne Therapeutics Announces Upcoming Presentations Across Neuromuscular Pipeline at 2026 MDA Clinical & Scientific Conference

GlobeNewswire
·
Feb 23

Cassava Announces Closure of U.S. Department of Justice Investigation

GlobeNewswire
·
Feb 19

Press Release: Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results

Dow Jones
·
Feb 19